UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 43

Sortiert nach

Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes

Diabetes care, 2018-04, Vol.41 (4), p.653-661

2018

Link zum Volltext

Verfügbarkeit prüfen

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials

Diabetes (New York, N.Y.), 2020-08, Vol.69 (8), p.1827-1832

2020

Link zum Volltext

Verfügbarkeit prüfen

Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention

Diabetes care, 2019-12, Vol.42 (12), p.2228-2236

2019

Link zum Volltext

Verfügbarkeit prüfen

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Diabetes care, 2015-02, Vol.38 (2), p.271-276

2015

Link zum Volltext

Verfügbarkeit prüfen

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 Participants

Diabetes (New York, N.Y.), 2013-12, Vol.62 (12), p.4179-4183

2013

Link zum Volltext

Verfügbarkeit prüfen

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236

Diabetes care, 2020-04, Vol.43 (4), p.934-934

2020

Link zum Volltext

Verfügbarkeit prüfen

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

Diabetes care, 2014-04, Vol.37 (4), p.979-984

2014

Link zum Volltext

Verfügbarkeit prüfen

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

Pediatric diabetes, 2009-03, Vol.10 (2), p.97-104

2009

Link zum Volltext

Verfügbarkeit prüfen

The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1

Pediatric diabetes, 2018-05, Vol.19 (3), p.403-409

2018

Link zum Volltext

Verfügbarkeit prüfen

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants

Diabetes care, 2010-03, Vol.33 (3), p.620-625

2010

Link zum Volltext

Verfügbarkeit prüfen

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787

Diabetes care, 2018-04, Vol.41 (4), p.913-913

2018

Link zum Volltext

Verfügbarkeit prüfen

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study

Diabetes technology & therapeutics, 2015-12, Vol.17 (12), p.867

2015

Link zum Volltext

Verfügbarkeit prüfen

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months

Diabetes care, 2015-05, Vol.38 (5), p.940-942

2015

Link zum Volltext

Verfügbarkeit prüfen

The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes

Diabetes care, 2012-07, Vol.35 (7), p.1552-1555

2012

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

Diabetes care, 2011-08, Vol.34 (8), p.1785-1787

2011

Link zum Volltext

Verfügbarkeit prüfen

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)

Diabetes (New York, N.Y.), 2010-10, Vol.59 (10), p.2386-2389

2010

Link zum Volltext

Verfügbarkeit prüfen

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Diabetes care, 2008-11, Vol.31 (11), p.2188-2192

2008

Link zum Volltext

Verfügbarkeit prüfen

Participant and Parent Experiences in the Parenteral Insulin Arm of the Diabetes Prevention Trial for Type 1 Diabetes

Diabetes care, 2007-09, Vol.30 (9), p.2193-2198

2007

Link zum Volltext

Verfügbarkeit prüfen

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1

Diabetes care, 2009-09, Vol.32 (9), p.1603-1607

2009

Link zum Volltext

Verfügbarkeit prüfen

Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network

Annals of the New York Academy of Sciences, 2008-12, Vol.1150 (1), p.14-24

2008

Link zum Volltext

Verfügbarkeit prüfen

Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes

Pediatric diabetes, 2009-05, Vol.10 (3), p.177-183

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes

Pediatric diabetes, 2015-06, Vol.16 (4), p.271-279

2015

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

Diabetes care, 2018-09, Vol.41 (9), p.1917-1925

2018

Link zum Volltext

Verfügbarkeit prüfen

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Diabetes (New York, N.Y.), 2019-06, Vol.68 (6), p.1267-1276

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)
Zeitungsartikel
(1)

Sprache

Englisch
(43)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(31)
Science & Technology
(31)
Female
(28)
Male
(28)
Endocrinology & Metabolism
(26)
Diabetes
(24)
Adolescent
(21)
Child
(21)
Adult
(20)
Biological And Medical Sciences
(16)
Diabetes Mellitus, Type 1 - Prevention & Control
(16)
Diabetes. Impaired Glucose Tolerance
(16)
Endocrine Pancreas. Apud Cells
(16)
Endocrinopathies
(16)
Medical Sciences
(16)
Etiopathogenesis. Screening. Investigations. Target Tissue Resistance
(15)
Type 1 Diabetes
(15)
Clinical Trials
(12)
Glucose Tolerance Test
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes

Slowed Metabolic Decline After 1 Year of Oral Insulin Treatment Among Individuals at High Risk for Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1) and TrialNet Oral Insulin Prevention Trials

Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention

A new approach for diagnosing type 1 diabetes in autoantibody-positive individuals based on prediction and natural history

Acceleration of the Loss of the First-Phase Insulin Response During the Progression to Type 1 Diabetes in Diabetes Prevention Trial―Type 1 Participants

Erratum. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care 2019;42:2228-2236

Use of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS) for Improving the Accuracy of the Risk Classification of Type 1 Diabetes

The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results

The influence of body mass index and age on C‐peptide at the diagnosis of type 1 diabetes in children who participated in the diabetes prevention trial‐type 1

Trends of Earlier and Later Responses of C-peptide to Oral Glucose Challenges With Progression to Type 1 Diabetes in Diabetes Prevention Trial-Type 1 Participants

Erratum. Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study. Diabetes Care 2011;34:1785-1787

Use of Dried Capillary Blood Sampling for Islet Autoantibody Screening in Relatives: A Feasibility Study

The development and utility of a novel scale that quantifies the glycemic progression toward type 1 diabetes over 6 months

The Application of the Diabetes Prevention Trial-Type 1 Risk Score for Identifying a Preclinical State of Type 1 Diabetes

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

Glucose Excursions Between States of Glycemia With Progression to Type 1 Diabetes in the Diabetes Prevention Trial-Type 1 (DPT-1)

Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial-Type 1

Participant and Parent Experiences in the Parenteral Insulin Arm of the Diabetes Prevention Trial for Type 1 Diabetes

Incident Dysglycemia and Progression to Type 1 Diabetes Among Participants in the Diabetes Prevention Trial-Type 1

Type 1 Diabetes TrialNet-An International Collaborative Clinical Trials Network

Participant and parent experiences in the oral insulin study of the Diabetes Prevention Trial for Type 1 Diabetes

Umbilical cord mesenchymal stem cells for COVID‐19 acute respiratory distress syndrome: A double‐blind, phase 1/2a, randomized controlled trial

Effect of docosahexaenoic acid supplementation on inflammatory cytokine levels in infants at high genetic risk for type 1 diabetes

Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes

Low-Dose Anti-Thymocyte Globulin Preserves C-Peptide, Reduces HbA1c, and Increases Regulatory to Conventional T-Cell Ratios in New-Onset Type 1 Diabetes: Two-Year Clinical Trial Data

Suchergebnisse filtern